Pro-inflammatory cytokines in rheumatoid arthritis: Pathogenetic and therapeutic aspects

Clinical Reviews in Allergy and Immunology

Volumn 28, Issue 3, 2005, Pages 239-248

  Smolen, Josef S ^a   Redlich, Kurt ^a   Zwerina, Jochen ^a   Aletaha, Daniel ^a   Steiner, Günter ^a   Schett, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anti IL 6R (tocilizumab); Anti TNF; Cytokines; Disease activity; IL 1; IL 1ra; IL 6; Joint damage; Osteoclasts; Rheumatoid arthritis; Therapy; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIRHEUMATIC AGENT; ATLIZUMAB; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HYPERLIPIDEMIA; IMMUNOPATHOGENESIS; INFECTION; INFECTION SENSITIVITY; INFLAMMATORY INFILTRATE; OSTEOCLAST; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; CYTOKINES; HUMANS;

EID: 23944476089     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:28:3:239     Document Type: Review

References (75)

1. Smolen, J. S., Breedveld, F. C., Eberl, G., et al. (1995), Arthritis Rheum. 38(1), 38-43.
2. Weichselbaum, A. (1878), Arch. Pathol. Anal. Physiol. Klin. Med. (Virchow's Arch.) 73, 461-475.
3. Felson, D. T., Anderson, J. J., Boers, M., et al. (1995), Arthritis Rheum. 38, 727-735.
4. Prevoo, M. L. L., van't Hof, M. A., Kuper, H. H., van de Putte, L. B. A., and van Riel, P. L. C. M. (1995), Arthritis Rheum. 38, 44-48.
5. Smolen, J. S., Breedveld, F. C., Schiff, M. H., et al. (2003), Rheumatology 42, 244-257.
6. Aletaha, D., Nell, V. P. K., Stamm, T., et al. (2005), Arthritus Res. Ther. 7, R796-R806.
7. van der Heijde, D., Simon, L., Smolen, J., et al. (2002), Arthritis Rheum. 47(2), 215-218.
8. Fries, J. F., Spitz, P. W., Kraines, R. G., and Holman, H. R. (1980), Arthritis Rheum. 23, 137-145.
9. Drossaers-Bakker, K. W., de Buck, M., van Zeben, D., Zwinderman, A. H., Breedveld, F. C., and Hazes, J. M. (1999), Arthritis Rheum. 42, 1854-1860.
10. Smolen, J. S., and Aletaha, D. (2004), Ann. Rheum. Dis. 63, 221-225.
11. Welsing, P. M., van Gestel, A. M., Swinkels, H. L., Kiemeney, L. A., and van Riel, P. L. (2001), Arthritis Rheum. 44(9), 2009-2017.
12. Smolen, J. S. and Steiner, G. (2003), Nat. Rev. Drug Discov. 2, 473-488.
13. Firestein, G. S. (2003), Nature 423[356], 361.
14. Partsch, G., Steiner, G., Leeb, B. F., Dunky, A., Broll, H., and Smolen, J. S. (1997), J. Rheumatol. 24, 518-523.
15. Steiner, G., Tohidast-Akrad, M., Witzmann, G., et al. (1999), Rheumatology (Oxford) 38, 202-213.
16. Firestein, G. S., Alvaro-Gracia, J. M., and Maki, R. (1990), J. Immunol. 144, 3347-3353.
17. Gregersen, P. K., Silver, J., and Winchester, R. J. (1987), Arthritis Rheum. 30, 1205-1213.
18. Steiner, G. and Smolen, J. S. (2002), Arthritis Res. 4(Suppl. 2), S1-S5.
19. Mattey, D. L., Dawes, P. T., Clarke, S., et al. (2002), Arthritis Rheum. 47, 403-407.
20. Ishikawa, H., Smiley, J. D., and Ziff, M. (1975), Arthritis Rheum. 18(6), 563-576.
21. Neumann, F., Barnum, S. R., Tarner, I. H., et al. (2002), Arthritis Rheum. 46(4), 934-945.
22. Debets, J. M., Van der Linden, C. J., Dieteren, I. E., Leeuwenberg, J. F., and Buurman, W. A. (1988), J. Immunol. 141, 1197-1201.
23. Keffer, J., Probert, L., Cazlaris, H., et al. (1991), EMBO J. 10, 4025-4031.
24. Horai, R., Saijo, S., Tanioka, H., et al. (2000), J. Exp. Med. 191(2), 313-320.
25. Takagi, N., Mihara, M., Moriya, Y., et al. (1998), Arthritis Rheum. 41, 2117-2121.
26. Brennan, F. M., Chantry, D., Jackson, A., Maini, R., and Feldmann, M. (1989), Lancet 2, 244-247.
27. Abramson, S. B. and Amin, A. (2002), Rheumatology (Oxford) 41(9), 972-980.
28. McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M., and Liew, F. Y. (1997), Nat. Med. 3, 189-195.
29. Phillip, R. and Epstein, L. B. (1986), Nature 323, 86-89.
30. Gravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., and Goldring, S. R. (1998), Am. J. Pathol. 152, 943-951.
31. Redlich, K., Hayer, S., Ricci, R., et al. (2002), J. Clin. Invest. 110(10), 1419-1427.
32. Pettit, A. R., Ji, H., von Stechow, D., et al. (2001), Am. J. Pathol. 159(5), 1689-1699.
33. Redlich, K., Hayer, S., Maier, A., et al. (2002), Arthritis Rheum. 46, 785-792.
34. Teitelbaum, S. L. (2000), Science 289, 1504-1508.
35. Kong, Y. Y., Feige, U., Sarosi, I., et al. (1999), Nature 402(6759), 304-309.
36. Abu-Amer, Y., Ross, F. P., Edwards, J., and Teitelbaum, S. L. (1997), J. Clin. Invest. 100, 1557-1565.
37. Kobayashi, K., Takahashi, N., Jimi, E., et al. (2000), J. Exp. Med. 191, 275-286.
38. Kotake, S., Sato, K., Kim, K. J., et al. (1996), J. Bone Miner. Res. 11, 88-95.
39. Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., and Teitelbaum, S. L. (2000), J. Clin. Invest. 106, 1481-1488.
40. Ma, T., Miyanishi, K., Suen, A., et al. (2004), Cytokine 26, 138-144.
41. Udagawa, N. (2002), Biogerontology 3, 79-83.
42. Goldring, S. R. (2003), Rheumatology 42(Suppl. 2), 11-16.
43. Lee, Z. H., Lee, S. E., Kim, C. W., et al. (2002), J. Biochem. (Tokyo) 131, 161-166.
44. Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., and Athanasou, N. A. (2003), Blood 32, 1-7.
45. Devlin, R. D., Reddy, S. V., Savino, R., Ciliberto, G., and Roodman, G. D. (1998), J. Bone Miner. Res. 13, 393-399.
46. Ragab, A. A., Nalepka, J. L., Bi, Y., and Greenfield, E. M. (2002), Am. J. Physiol. Cell Physiol. 283, C679-C687.
47. Bathon, J. M., Martin, R. W., Fleischmann, R. M., et al. (2000), N. Engl. J. Med. 343(22), 1586-1593.
48. Elliott, M. J., Maini, R. N., Feldmann, M., et al. (1994), Lancet 344(8930), 1105-1110.
49. Keystone, E., Kavanaugh, A. F., Sharp, J., et al. (2002), Arthritis Rheum. 46(Suppl.), S205.
50. Lipsky, P. E., Van der Heijde, D. M., St. Clair, E. W., et al. (2000), N. Engl. J. Med. 343(22), 1594-1602.
51. Maini, R. N., Breedveld, F. C., Kalden, J. R., et al. (1998), Arthritis Rheum. 41(9), 1552-1563.
52. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., et al. (1997), N. Engl. J. Med. 337(3), 141-147.
53. St. Clair, E. W., van der Heijde, D. M., Smolen, J. S., et al. (2004), Arthritis Rheum. 50, 3432-3443.
54. Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., et al. (1999), N. Engl. J. Med. 340(4), 253-259.
55. Zwerina, J., Redlich, K., Kollias, G., Smolen, J. S., and Schett, G. (2004), Arthritis Rheum. 50, 177-190.
56. Smolen, J. S., Han, C., Bala, M., et al. (2005), Arthritis Rheum. 52, 1020-1030.
57. Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., et al. (1998), Arthritis Rheum. 41(12), 2196-2204.
58. Burger, D., Chicheportiche, R., Giri, J. G., and Dayer, J. M. (1995), J. Clin. Invest. 96(1), 38-41.
59. Pavelka, K., Kuba, V., Moeller Rasmussen, J., et al. (2002), American College of Rheumatology 66th Annual Scientific Meeting, Late breaking Abstract.
60. Seitz, M., Zwicker, M., and Loetscher, P. (1998), Arthritis Rheum. 41(11), 2032-2038.
61. Klareskog, L., van der Heijde, D., de Jager, J. P., et al. (2004), Lancet 363, 675-681.
62. Hawkins, P. N., Lachmann, H. J., and McDermott, M. F. (2003), N. Engl. J. Med. 348, 2583-2584.
63. Naka, T., Nishimoto, N., and Kishimoto, T. (2002), Arthritis Res. 4(Suppl. 3), S233-S242.
64. Nishimoto, N., Yoshizaki, K., and Kishimoto, T. (2003), Interleukin-6. In: Smolen, J. S. and Lipsky, P. E., eds. Targeted Therapies in Rheumatology. London-New York: Martin Dunitz, 231-241.
65. Wendling, D., Racadot, E., and Wijdenes, J. (1993), J. Rheumatol. 20(2), 259-262.
66. Choy, E. H., Isenberg, D. A., Garrood, T., et al. (2002), Arthritis Rheum. 46(12), 3143-3150.
67. Nishimoto, N., Yoshizaki, K., Maeda, K., et al. (2003), J. Rheumatol. 30, 1426-1435.
68. Nishimoto, N., Yoshizaki, K., Miyasaka, N., et al. (2004), Arthritis Rheum. 50, 1761-1769.
69. Maini, R. and The Charisma Study group. (2003), Ann. Rheum. Dis. 62(Suppl. 1), OP002 (Abstract).
70. Redlich, K., Schett, G., Steiner, G., Hayer, S., Wagner, E. F., and Smolen, J. S. (2003), Arthritis Rheum. 48, 3308-3319.
71. Edwards, J. C., Szczepanski, L., Szechinski, J., et al. (2004), N. Engl. J. Med. 350, 2572-2581.
72. Kremer, J. M., Westhovens, R., Leon, M., et al. (2003), N. Engl. J. Med. 349, 1907-1915.
73. Redlich, K., Görtz, B., Hayer, S., et al. (2004), Am. J. Pathol. 164, 543-555.
74. Aletaha, D. and Smolen, J. S. (2004), Ann. Rheum. Dis. 63, 221-225.
75. Smolen, J. S., Sokka, T., Pincus, T., and Breedveld, F. C. (2003), Clin. Exp. Rheumatol. 21(Suppl. 31), S209, S210.